John Turnbull

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Platform Trials in ALS.

Platform Trials in ALS.

Journal: JAMA

Published: February 17, 2025

Rare neurovascular genetic and imaging markers across neurodegenerative diseases.

Rare neurovascular genetic and imaging markers across neurodegenerative diseases.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 03, 2023

Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function.

Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Published: January 13, 2023

Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.

Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.

Journal: Physical therapy

Published: November 26, 2022

White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.

White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.

Journal: Alzheimer's research & therapy

Published: September 13, 2022

Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases.

Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases.

Journal: Brain communications

Published: August 05, 2022

Refining items for a preference-based, amyotrophic lateral sclerosis specific, health-related quality of life scale.

Refining items for a preference-based, amyotrophic lateral sclerosis specific, health-related quality of life scale.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: February 11, 2022

MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design.

MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design.

Journal: Neurodegenerative disease management

Published: November 24, 2021

Targeted copy number variant identification across the neurodegenerative disease spectrum.

Targeted copy number variant identification across the neurodegenerative disease spectrum.

Journal: Molecular genetics & genomic medicine

Published: November 21, 2021

Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases.

Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases.

Journal: GeroScience

Published: August 17, 2021

Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort.

Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 29, 2021

Contribution of rare variant associations to neurodegenerative disease presentation.

Contribution of rare variant associations to neurodegenerative disease presentation.

Journal: NPJ genomic medicine

Published: April 27, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026